What's new

Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn

Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn

Apr 9, 2025 - 09:35
 0
Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn
Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn
Read More

Tags:

Previous Article

Public health leaders, besieged and regretful, talk of re-establishing trust

Next Article

Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral scl...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Rapiscan, Regadenoson, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: P/0029/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 18, 2025  0

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025  0

Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0